Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AdaptHealth (AHCO) Other Non-Current Assets (2018 - 2025)

AdaptHealth (AHCO) has 8 years of Other Non-Current Assets data on record, last reported at $18.7 million in Q3 2025.

  • For Q3 2025, Other Non-Current Assets rose 8.7% year-over-year to $18.7 million; the TTM value through Sep 2025 reached $18.7 million, up 8.7%, while the annual FY2024 figure was $17.6 million, N/A changed from the prior year.
  • Other Non-Current Assets reached $18.7 million in Q3 2025 per AHCO's latest filing, roughly flat from $18.8 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $22.5 million in Q3 2023 and bottomed at $12.1 million in Q3 2021.
  • Average Other Non-Current Assets over 5 years is $18.6 million, with a median of $19.0 million recorded in 2021.
  • Peak YoY movement for Other Non-Current Assets: soared 238.68% in 2021, then dropped 23.46% in 2024.
  • A 5-year view of Other Non-Current Assets shows it stood at $15.1 million in 2021, then surged by 48.46% to $22.4 million in 2022, then rose by 0.4% to $22.5 million in 2023, then dropped by 21.86% to $17.6 million in 2024, then increased by 6.47% to $18.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Non-Current Assets were $18.7 million in Q3 2025, $18.8 million in Q2 2025, and $18.9 million in Q1 2025.